Dr. Dennis Wagner is currently the Medical Advisor (Medical Affairs Lead) for Hematology/Oncology at AstraZeneca Canada Inc. Previously, Dennis served as a Senior Medical Scientist in Oncology with Gilead Sciences Inc. Dennis began his career at GlaxoSmithKline Inc (GSK) in 2012, first as a Medical Science Liaison (MSL) and later as a Scientific Advisor in Oncology. In these Medical Affairs roles, Dennis has launched several key drugs in Oncology/Hematology, providing scientific/clinical support, leadership and expertise to key external physicians/HCPs, as well as to internal company stakeholders.
Dennis completed his PhD at the University of Toronto, where he directed a clinical trial of vitamin D supplementation in prostate cancer patients undergoing prostate surgery. While pursuing his PhD, Dennis also co-founded and managed a small consulting firm that provided contract consulting support to management consulting firms and life science companies. He also served as a co-president of the Life Sciences Career Development Society (LSCDS) at the University of Toronto (2011-2012).